RE:stockbaboon, u have no idea what u talkin about (again)They are still deciding to pull kidney or liver back on table for phase 2 or just let it die and take it private and sell to Boehringher knowing that they can do trials safely with triple dose levels of previous trials. I imagine Alstrom syndrome patients would love triple doses but will Thomfvck hang around or steal whole company and sell it.
Newcamo wrote: pbi4050 is on hold..wait for MAD.... how good is that piper price target of 4.50$ couple days before FDA ok:))))all b.s.... i told u...sharks..... u need to learn how to play, or dont play! These shares have a lot to go next week, but they were available all this week;) what did u say? plant not inspected? what did i say? No way kedrion would have made a deal with zero chance of fda approval... of course it was inspected and check points were all good.
so, suck it up, buy, dont buy, who cares.
:)